Logo image
Back
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model
Journal article   Open access   Peer reviewed

Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model

M S Whitman, P G Pitsakis, E DeJesus, A J Osborne, M E Levison and C C Johnson
Antimicrobial agents and chemotherapy, v 40(6), pp 1526-1530
Jun 1996
DOI: https://doi.org/10.1128/aac.40.6.1526
PMID: 8726031
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1128/aac.40.6.1526View
Published, Version of Record (VoR)Open Access (License Unspecified),  Open

Abstract

Administration, Oral Animals Anti-Bacterial Agents - pharmacology Depsipeptides Digestive System - drug effects Digestive System - microbiology Disease Models, Animal Drug Resistance, Microbial Enterococcus faecium - drug effects Enterococcus faecium - isolation & purification Female Mice Microbial Sensitivity Tests Peptides, Cyclic Streptomycin - pharmacology Vancomycin - pharmacology
Vancomycin-resistant enterococci have become important nosocomial pathogens in many institutions. The gastrointestinal tract of susceptible hosts serves as the likely reservoir from which the organism is disseminated. To study factors promoting colonization and the efficacy of decontamination therapy with antimicrobial agents, a model of gastrointestinal colonization with vancomycin-resistant Enterococcus faecium was developed in CF1 mice. At baseline, all animals were colonized with non-vancomycin-resistant enterococci (5.0 log10 CFU/g), but vancomycin-resistant organisms were not detectable. Following gastric inoculation with 5 x 10(8) CFU of a clinical isolate of vancomycin-resistant E. faecium, the strain transiently colonized the gastrointestinal tract of 100% of mice but was undetectable by Day 14 (< or = 2.7 log10 mean CFU/g). In animals who received 5 mg of streptomycin per ml or 250 micrograms of vancomycin per ml in drinking water, colonization with the organism occurred at significantly higher bacterial counts than in controls at 7 days following inoculation (9.4 for vancomycin, 9.2 for streptomycin, and 5.1 log10 mean CFU/g for controls; P < 0.05). Fecal concentrations of vancomycin-resistant E. faecium persisted at high counts through Day 22 in mice receiving these antibiotics, but low counts were also still detected in 3 of 10 control animals. In mice with previously established vancomycin-resistant E. faecium colonization, oral administration of ramoplanin, a lipoglycodepsipeptide to which the strain was susceptible, suppressed growth of all enterococci in feces, including the vancomycin-resistant strain after 7 days of therapy (< or = 3.1 and < or = 3.3 log10 mean CFU/g for vancomycin and streptomycin groups, respectively). All mice had a recurrence of colonization with vancomycin-resistant E. faecium after the ramoplanin was discontinued. In summary, this animal model demonstrates the importance of antibiotics in predisposing to gastrointestinal colonization with vancomycin-resistant Enterococcus spp. Although treatment with ramoplanin temporarily suppressed the organism, recurrence of colonization due to relapse or reinfection occurred.

Metrics

9 Record Views
33 citations in Web of Science
38 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Microbiology
Pharmacology & Pharmacy
Logo image